Cor Vasa 2009, 51(10):685-690 | DOI: 10.33678/cor.2009.170

The changing spectrum of risk factors for coronary heart disease

Vladimír Staněk1,*, Renata Cífková2, Marie Gebauerová1, Alena Lorencová3, Rudolf Poledne3, Věra Lánská4
1 Klinika kardiologie
2 Pracoviště preventivní kardiologie
3 Laboratoř pro výzkum aterosklerózy
4 Oddělení statistiky, Institut klinické a experimentální medicíny, Praha, Česká republika

Aims: The aim of the study was to assess conventional and newer emerging risk factors in cases with acute coronary syndrome (ACS) and in apparently healthy controls selected from a random population sample.

Methods and results: Conventional risk factors for coronary heart disease and anthropometric data were analyzed in a group of 284 men and 50 women below 65 years of age, admitted for non-fatal ACS associated with an increase in cardiospecific enzymes. A control group comprised 794 and 960 men and women of similar age, selected from a Czech random population sample.
Men with ACS were found to have similar levels of total (6.04 ± 1.11 vs 6.09 ± 1.02 mmol/l, NS) and LDL-cholesterol (3.81 ± 1.02 vs 3.93 ± 0.91 mmol/l, NS) and lower levels of HDL-cholesterol (1.16 ± 0.32 vs 1.25 ± 0.33 mmol/l, p < 0.01). Smoking (70.1 % vs 34.1%, p < 0.001) and diabetes (22.5% vs 7.7%, p < 0.001) were more prevalent in the ACS group compared with controls. Men with ACS showed similar BMI (28.2 ± 4.1 vs 29.0 ± 4.4 kg/m2, NS), yet bigger waist circumference (102.7 ± 10.3 vs 99.9 ± 11.2 cm, p < 0,001) and smaller hip circumference (98.0 ± 9.6 and 105.0 ± 7.8 cm, p < 0.001). Triglyceride levels, as measured in the acute phase of the disease, did not differ in male patients and controls (1.90 ± 1,26 vs 2.15 ± 1.37 mmol/l, NS). Prevalence of hypertension was lower in male cases than in controls (41.0% vs 55.5%, p < 0,001). Diabetes affected 22.0% of male ACS patients compared with 7.1% of controls (p < 0.001).
In females, the differences between patients and controls were similar. Females with ACS and controls had comparable total (6.29 ± 1.17 vs 6.24 ± 1.13 mmol/l, NS) and LDL-cholesterol (4.05 ± 1.0 vs 4.02 ± 1.0 mmol/l, NS). HDL-cholesterol was lower in the diseased group (1.24 ± 0.34 vs 1.7 ± 0.38 mmol/l, p < 0.001) while triglycerides did not show any difference (1.78 ± 1.00 vs 1.69 ± 0.96 mmol/l, NS). There were more smokers (76.1 % vs 23.5%, p < 0.001) and more diabetics (33.3 % vs 7.2%, p < 0.001) among females with ACS; their waist circumference was bigger (97.1 ± 10.0 vs 90.2 ± 13.2 cm, p < 0.001) and hip circumference smaller (101.0 ± 7.4 vs 108.2 ± 11.2 cm, p < 0.001), BMI did not differ (28.4 ± 5.5 vs 29.2 ± 5.7 kg/m2, NS). Similar prevalence rates for hypertension were found in female cases and controls (52.4% vs 48.9%, NS).
After adjustment for hypertension, triglycerides > 1.69 mmol/l, HDL-cholesterol < 1.04 mmol/l and BMI > 30 kg/m2) in males, logistic regression analysis revealed odds ratios of 5.14 for diabetes, 4.06 for waist circumference, 4.96 for smoking, and 1.33 for total cholesterol.

Conclusion: Central obesity in middle-aged Prague residents seems to be a risk factor more powerful than hypertension and increased total and LDL-cholesterol.

Keywords: Acute coronary syndrom; Risk factors for CHD; Central obesity; Metabolic syndrome

Published: October 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Staněk V, Cífková R, Gebauerová M, Lorencová A, Poledne R, Lánská V. The changing spectrum of risk factors for coronary heart disease. Cor Vasa. 2009;51(10):685-690. doi: 10.33678/cor.2009.170.
Download citation

References

  1. Verschuren WMM, Jacobs DR, Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995;274: 131-6. Go to original source...
  2. Cífková R, Škodová Z, Lánská V, et al. Prevalence, awareness, treatment and control of hypertension in the Czech Republic: Results of two nationwide cross-sectional surveys in 1997/1998 and 200/2001, Czech-Post MONICA Study. J Hum Hypertens 2004;18:571-9. Go to original source... Go to PubMed...
  3. Friedewald WT, Levy RI, Frederikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502. Go to original source...
  4. Molarius A, Seidell JC. Selection of anthropometric indicators for classification of abdominal fatness - a critical review. Int J Obes Relat Metab Disord 1998;22:719-22. Go to original source... Go to PubMed...
  5. Rimm EB, Stampfer MJ, Giovanucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995;141:1117-27. Go to original source...
  6. Larsson B, Svardsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13-year follow-up of participants in a study of men born in 1913. Br Med J 1984;288: 1401-4. Go to original source... Go to PubMed...
  7. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-8. Go to original source... Go to PubMed...
  8. Despres JP. Health consequences of visceral obesity. Ann Med 2001;33: 534-41.
  9. Grundy SM. Metabolic complications of obesity. Endocrine 2000;13: 155-65 Go to original source... Go to PubMed...
  10. Rosenson RS. Myocardial injury: The acute phase response and lipoprotein metabolism. JACC 1993;22:933-40. Go to original source... Go to PubMed...
  11. Kawano M, Namai K, Yaginuma T, et al. Letter to the editors. Atherosclerosis 2001;156:477-8. Go to original source...
  12. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1974;344:1383.
  13. Franklin K, Goldberg RJ, Spencer F, et al, for the GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. Arch Intern Med 2004;164:1457-63 Go to original source... Go to PubMed...
  14. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemilogy Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet 1999:354:617-21.
  15. Feldman M, Jialal I, Devaraj S, Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001;37:2036-41. Go to original source...
  16. Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998;98:839-44. Go to original source...
  17. Ridker PM, Rifai N, Pfeffer MA, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-5. Go to original source...
  18. Grundy SM, Small LDL. Atheroglenic dyslipidemia and the metabolic syndrome. Circulation 1997;95:1-4. Go to original source...
  19. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults: Third report of the National Cholesterol Education Program (NCEP - Adult Treatment Panel III) executive summary. Washington, DC: US Department of Health and Human Services, 2001:1-30.
  20. Cífková R, Škodová Z. Dlouhodobé trendy hlavních rizikových faktorů kardiovaskulárních onemocnění v české populaci. Čs Lék čes 2004;143:219-26.
  21. Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow-up of participants in the population study of women in Gothenburg. Br Med J 1984;289: 1257-61. Go to original source... Go to PubMed...
  22. Rayner M, Peterson S. European cardiovascular disease statistic. London: British Heart Foundation Health Promotion Research Group, 2000.
  23. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation 2003; 108:1552-3. Go to original source... Go to PubMed...
  24. Ninomiya JK, L'Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 2004;109: 42-6. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.